N-glycomic biomarkers of biological aging and longevity: A link with inflammaging

Ageing Research Reviews

Volumn 12, Issue 2, 2013, Pages 685-698

  Dall'Olio, Fabio ^a   Vanhooren, Valerie ^b,c   Chen, Cuiying Chitty ^b,c   Slagboom, P Eline ^d   Wuhrer, Manfred ^d   Franceschi, Claudio ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

^c GHENT UNIVERSITY   (Belgium)

^d LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Antibody glycosylation; Autoimmune disease; Glycosylation; High throughput glycomic analysis; Inflammaging; Rheumatoid arthritis

Indexed keywords

ASPARAGINE; AUTOANTIBODY; BIOLOGICAL MARKER; FC RECEPTOR; GALACTOSE; GLYCAN; IMMUNOGLOBULIN G; LECTIN; MANNOSE BINDING LECTIN;

AGE DISTRIBUTION; AGING; BIOSYNTHESIS; CALORIC RESTRICTION; CARBOHYDRATE ANALYSIS; GLYCOBIOLOGY; GLYCOSYLATION; HUMAN; IMMUNE DEFICIENCY; IMMUNITY ACTIVATION; IMMUNOLOGICAL PARAMETERS; INFLAMMAGING; INFLAMMATION; METABOLISM; MODULATION; MOLECULAR BIOLOGY; MOLECULAR INTERACTION; NONHUMAN; PROTEIN PROCESSING; REVIEW; THEORY;

AGED; AGING; ANIMALS; ASPARAGINE; AUTOIMMUNE DISEASES; BIOLOGICAL MARKERS; COMPLEMENT PATHWAY, MANNOSE-BINDING LECTIN; FEEDBACK, PHYSIOLOGICAL; GLYCOMICS; GLYCOSYLATION; HUMANS; IMMUNOGLOBULIN G; INFLAMMATION; MICE; MODELS, THEORETICAL; POLYSACCHARIDES; PROGERIA; PROTEIN PROCESSING, POST-TRANSLATIONAL;

MUS;

EID: 84878551340     PISSN: 15681637     EISSN: 18729649     Source Type: Journal    
DOI: 10.1016/j.arr.2012.02.002     Document Type: Review

References (219)

1. Adler Y., Lamour A., Jamin C., Menez J.F., Le Corre R., Shoenfeld Y., Youinou P. Impaired binding capacity of asialyl and agalactosyl IgG to Fcγ receptors. Clin. Exp. Rheumatol. 1995, 13:315-319.
2. Alavi A., Arden N., Spector T.D., Axford J.S. Immunoglobulin G glycosylation and clinical outcome in rheumatoid arthritis during pregnancy. J. Rheumatol. 2000, 27:1379-1385.
3. Alavi A., Axford J. Evaluation of β1,4-galactosyltransferase in rheumatoid arthritis and its role in the glycosylation network associated with this disease. Glycoconj. J. 1995, 12:206-210.
4. Alavi A., Axford J. β1,4-galactosyltransferase variations in rheumatoid arthritis. Adv. Exp. Med. Biol. 1995, 376:185-192.
5. Alavi A., Axford J.S., Hay F.C., Jones M.G. Tissue-specific galactosyltransferase abnormalities in an experimental model of rheumatoid arthritis. Ann. Med. Interne (Paris) 1998, 149:251-260.
6. Alavi A., Axford J.S., Pool A.J. Serum galactosyltransferase isoform changes in rheumatoid arthritis. J. Rheumatol. 2004, 31:1513-1520.
7. Albert H., Collin M., Dudziak D., Ravetch J.V., Nimmerjahn F. In vivo enzymatic modulation of IgG glycosylation inhibits autoimmune disease in an IgG subclass-dependent manner. Proc. Natl. Acad. Sci. U.S.A. 2008, 105:15005-15009.
8. Anthony R.M., Kobayashi T., Wermeling F., Ravetch J.V. Intravenous gammaglobulin suppresses inflammation through a novel TH2 pathway. Nature 2011, 475:110-113.
9. Anthony R.M., Nimmerjahn F., Ashline D.J., Reinhold V.N., Paulson J.C., Ravetch J.V. Recapitulation of IVIG anti-inflammatory activity with a recombinant IgG Fc. Science 2008, 320:373-376.
10. Anthony R.M., Wermeling F., Karlsson M.C., Ravetch J.V. Identification of a receptor required for the anti-inflammatory activity of IVIG. Proc. Natl. Acad. Sci. U.S.A. 2008, 105:19571-19578.
11. Arnold J.N., Dwek R.A., Rudd P.M., Sim R.B. Mannan binding lectin and its interaction with immunoglobulins in health and in disease. Immunol. Lett. 2006, 106:103-110.
12. Arnold J.N., Saldova R., Hamid U.M., Rudd P.M. Evaluation of the serum N-linked glycome for the diagnosis of cancer and chronic inflammation. Proteomics 2008, 8:3284-3293.
13. Arnold J.N., Wormald M.R., Sim R.B., Rudd P.M., Dwek R.A. The impact of glycosylation on the biological function and structure of human immunoglobulins. Annu. Rev. Immunol. 2007, 25:21-50.
14. Axford J.S., Alavi A., Bond A., Hay F.C. Differential B lymphocyte galactosyltransferase activity in the MRL mouse model of rheumatoid arthritis. Autoimmunity 1994, 17:157-163.
15. Axford J.S., Cunnane G., Fitzgerald O., Bland J.M., Bresnihan B., Frears E.R. Rheumatic disease differentiation using immunoglobulin G sugar printing by high density electrophoresis. J. Rheumatol. 2003, 30:2540-2546.
16. Axford J.S., Mackenzie L., Lydyard P.M., Hay F.C., Isenberg D.A., Roitt I.M. Reduced B-cell galactosyltransferase activity in rheumatoid arthritis. Lancet 1987, 2:1486-1488.
17. Axford J.S., Sumar N., Alavi A., Isenberg D.A., Young A., Bodman K.B., Roitt I.M. Changes in normal glycosylation mechanisms in autoimmune rheumatic disease. J. Clin. Invest. 1992, 89:1021-1031.
18. Baerenwaldt A., Biburger M., Nimmerjahn F. Mechanisms of action of intravenous immunoglobulins. Expert Rev. Clin. Immunol. 2010, 6:425-434.
19. Barb A.W., Prestegard J.H. NMR analysis demonstrates immunoglobulin G N-glycans are accessible and dynamic. Nat. Chem. Biol. 2011, 7:147-153.
20. Barker R.N., Young R.D., Leader K.A., Elson C.J. Galactosylation of serum IgG and autoantibodies in murine models of autoimmune haemolytic anaemia. Clin. Exp. Immunol. 1999, 117:449-454.
21. Biagi E., Candela M., Franceschi C., Brigidi P. The aging gut microbiota: new perspectives. Ageing Res. Rev. 2011, 10:428-429.
22. Biagi E., Nylund L., Candela M., Ostan R., Bucci L., Pini E., Nikkila J., Monti D., Satokari R., Franceschi C., Brigidi P., De Vos W. Through ageing, and beyond: gut microbiota and inflammatory status in seniors and centenarians. PLoS ONE 2010, 5:e10667.
23. Bodman K.B., Hutchings P.R., Jeddi P.A., Delves P.J., Rook G.A., Sumar N., Roitt I.M., Lydyard P.M. IgG glycosylation in autoimmune-prone strains of mice. Clin. Exp. Immunol. 1994, 95:103-107.
24. Bodman K.B., Sumar N., Mackenzie L.E., Isenberg D.A., Hay F.C., Roitt I.M., Lydyard P.M. Lymphocytes from patients with rheumatoid arthritis produce agalactosylated IgG in vitro. Clin. Exp. Immunol. 1992, 88:420-423.
25. Bonafe M., Storci G., Franceschi C. Inflamm-aging of the stem cell niche: breast cancer as a paradigmatic example: breakdown of the multi-shell cytokine network fuels cancer in aged people. Bioessays 2012, 34:40-49.
26. Bones J., Byrne J.C., O'Donoghue N., McManus C., Scaife C., Boissin H., Nastase A., Rudd P.M. Glycomic and glycoproteomic analysis of serum from patients with stomach cancer reveals potential markers arising from host defense response mechanisms. J. Proteome Res. 2011, 10:1246-1265.
27. Callewaert N., Geysens S., Molemans F., Contreras R. Ultrasensitive profiling and sequencing of N-linked oligosaccharides using standard DNA-sequencing equipment. Glycobiology 2001, 11:275-281.
28. Cevenini E., Bellavista E., Tieri P., Castellani G., Lescai F., Francesconi M., Mishto M., Santoro A., Valensin S., Salvioli S., Capri M., Zaikin A., Monti D., de Magalhaes J.P., Franceschi C. Systems biology and longevity: an emerging approach to identify innovative anti-aging targets and strategies. Curr. Pharm. Des. 2010, 16:802-813.
29. Cevenini E., Caruso C., Candore G., Capri M., Nuzzo D., Duro G., Rizzo C., Colonna-Romano G., Lio D., Di Carlo D., Palmas M.G., Scurti M., Pini E., Franceschi C., Vasto S. Age-related inflammation: the contribution of different organs, tissues and systems. How to face it for therapeutic approaches. Curr. Pharm. Des. 2010, 16:609-618.
30. Childs R.A., Palma A.S., Wharton S., Matrosovich T., Liu Y., Chai W., Campanero-Rhodes M.A., Zhang Y., Eickmann M., Kiso M., Hay A., Matrosovich M., Feizi T. Receptor-binding specificity of pandemic influenza A (H1N1) 2009 virus determined by carbohydrate microarray. Nat. Biotechnol. 2009, 27:797-799.
31. Chiricolo M., Malagolini N., Bonfiglioli S., Dall'Olio F. Phenotypic changes induced by expression of β-galactoside α2,6 sialyltransferase I in the human colon cancer cell line SW948. Glycobiology 2006, 16:146-154.
32. Cingle K.A., Kalski R.S., Bruner W.E., O'Brien C.M., Erhard P., Wyszynski R.E. Age-related changes of glycosidases in human retinal pigment epithelium. Curr. Eye Res. 1996, 15:433-438.
33. Croce A., Firuzi O., Altieri F., Eufemi M., Agostino R., Priori R., Bombardieri M., Alessandri C., Valesini G., Saso L. Effect of infliximab on the glycosylation of IgG of patients with rheumatoid arthritis. J. Clin. Lab. Anal. 2007, 21:303-314.
34. Dahms N.M., Lobel P., Kornfeld S. Mannose 6-phosphate receptors and lysosomal enzyme targeting. J. Biol. Chem. 1989, 264:12115-12118.
35. Dall'Olio F., Malagolini N., Chiricolo M. Glycosylation in cancer. Spec. Periodical Rep. Carbohydr. Chem. 2012, 37:21-56.
36. Dall'Olio F., Malagolini N., Trinchera M., Chiricolo M. Mechanisms of cancer-associated glycosylation changes. Front. Biosci. 2012, 17:670-699.
37. Das H., Atsumi T., Fukushima Y., Shibuya H., Ito K., Yamada Y., Amasaki Y., Ichikawa K., Amengual O., Koike T. Diagnostic value of antiagalactosyl IgG antibodies in rheumatoid arthritis. Clin. Rheumatol. 2004, 23:218-222.
38. Davies J., Jiang L., Pan L.Z., LaBarre M.J., Anderson D., Reff M. Expression of GnTIII in a recombinant anti-CD20 CHO production cell line: expression of antibodies with altered glycoforms leads to an increase in ADCC through higher affinity for FC gamma RIII. Biotechnol. Bioeng. 2001, 74:288-294.
39. Delves P.J., Lund T., Axford J.S., Alavi-Sadrieh A., Lydyard P.M., Mackenzie L., Smith M.D., Kidd V.J. Polymorphism and expression of the galactosyltransferase-associated protein kinase gene in normal individuals and galactosylation-defective rheumatoid arthritis patients. Arthritis Rheum. 1990, 33:1655-1664.
40. Dong X., Storkus W.J., Salter R.D. Binding and uptake of agalactosyl IgG by mannose receptor on macrophages and dendritic cells. J. Immunol. 1999, 163:5427-5434.
41. Dube R., Rook G.A., Steele J., Brealey R., Dwek R., Rademacher T., Lennard-Jones J. Agalactosyl IgG in inflammatory bowel disease: correlation with C-reactive protein. Gut 1990, 31:431-434.
42. Endo T., Iwakura Y., Kobata A. Structural changes in the N-linked sugar chains of serum immunoglobulin G of HTLV-I transgenic mice. Biochem. Biophys. Res. Commun. 1993, 192:1004-1010.
43. Endo T., Kochibe N., Kobata A. Structural study of the carbohydrate moieties of two human immunoglobulin subclasses (IgG2 and IgG4). Glycoconj. J. 1989, 6:57-66.
44. Ercan A., Cui J., Chatterton D.E., Deane K.D., Hazen M.M., Brintnell W., O'Donnell C.I., Derber L.A., Weinblatt M.E., Shadick N.A., Bell D.A., Cairns E., Solomon D.H., Holers V.M., Rudd P.M., Lee D.M. Aberrant IgG galactosylation precedes disease onset, correlates with disease activity, and is prevalent in autoantibodies in rheumatoid arthritis. Arthritis Rheum. 2010, 62:2239-2248.
45. Ezekowitz R.A. Agalactosyl IgG and mannose-binding proteins: biochemical nicety or pathophysiological paradigm?. Nat. Med. 1995, 1:207-208.
46. Ferrara C., Grau S., Jager C., Sondermann P., Brunker P., Waldhauer I., Hennig M., Ruf A., Rufer A.C., Stihle M., Umana P., Benz J. Unique carbohydrate-carbohydrate interactions are required for high affinity binding between FcγRIII and antibodies lacking core fucose. Proc. Natl. Acad. Sci. U.S.A. 2011, 108:12669-12674.
47. Field M.C., Amatayakul-Chantler S., Rademacher T.W., Rudd P.M., Dwek R.A. Structural analysis of the N-glycans from human immunoglobulin A1: comparison of normal human serum immunoglobulin A1 with that isolated from patients with rheumatoid arthritis. Biochem. J. 1994, 299(Pt 1):261-275.
48. Filley E., Andreoli A., Steele J., Waters M., Wagner D., Nelson D., Tung K., Rademacher T., Dwek R., Rook G.A. A transient rise in agalactosyl IgG correlating with free interleukin 2 receptors, during episodes of erythema nodosum leprosum. Clin. Exp. Immunol. 1989, 76:343-347.
49. Flogel M., Lauc G., Gornik I., Macek B. Fucosylation and galactosylation of IgG heavy chains differ between acute and remission phases of juvenile chronic arthritis. Clin. Chem. Lab. Med. 1998, 36:99-102.
50. Franceschi C. Inflammaging as a major characteristic of old people: can it be prevented or cured?. Nutr. Rev. 2007, 65:S173-S176.
51. Franceschi C., Bonafe M., Valensin S., Olivieri F., De Luca M., Ottaviani E., De Benedictis G. Inflamm-aging. An evolutionary perspective on immunosenescence. Ann. N. Y. Acad. Sci. 2000, 908:244-254.
52. Franceschi C., Capri M., Monti D., Giunta S., Olivieri F., Sevini F., Panourgia M.P., Invidia L., Celani L., Scurti M., Cevenini E., Castellani G.C., Salvioli S. Inflammaging and anti-inflammaging: a systemic perspective on aging and longevity emerged from studies in humans. Mech. Ageing Dev. 2007, 128:92-105.
53. Furukawa K., Matsuta K., Takeuchi F., Kosuge E., Miyamoto T., Kobata A. Kinetic study of a galactosyltransferase in the B cells of patients with rheumatoid arthritis. Int. Immunol. 1990, 2:105-112.
54. Garred P., Madsen H.O., Marquart H., Hansen T.M., Sorensen S.F., Petersen J., Volck B., Svejgaard A., Graudal N.A., Rudd P.M., Dwek R.A., Sim R.B., Andersen V. Two edged role of mannose binding lectin in rheumatoid arthritis: a cross sectional study. J. Rheumatol. 2000, 27:26-34.
55. Ghosh P., Dahms N.M., Kornfeld S. Mannose 6-phosphate receptors: new twists in the tale. Nat. Rev. Mol. Cell Biol. 2003, 4:202-212.
56. Gornik I., Maravic G., Dumic J., Flogel M., Lauc G. Fucosylation of IgG heavy chains is increased in rheumatoid arthritis. Clin. Biochem. 1999, 32:605-608.
57. Gornik O., Wagner J., Pucic M., Knezevic A., Redzic I., Lauc G. Stability of N-glycan profiles in human plasma. Glycobiology 2009, 19:1547-1553.
58. Griffiths H.R., Lunec J. The effects of oxygen free radicals on the carbohydrate moiety of IgG. FEBS Lett. 1989, 245:95-99.
59. Groenink J., Spijker J., van den Herik-Oudijk I.E., Boeije L., Rook G., Aarden L., Smeenk R., van de Winkel J.G., van den Broek M.F. On the interaction between agalactosyl IgG and Fc gamma receptors. Eur. J. Immunol. 1996, 26:1404-1407.
60. Gui H.L., Gao C.F., Wang H., Liu X.E., Xie Q., Dewaele S., Wang L., Zhuang H., Contreras R., Libert C., Chen C. Altered serum N-glycomics in chronic hepatitis B patients. Liver Int. 2010, 30:259-267.
61. Guo S., Sato T., Shirane K., Furukawa K. Galactosylation of N-linked oligosaccharides by human β-1,4-galactosyltransferases I, II, III, IV, V, and VI expressed in Sf-9 cells. Glycobiology 2001, 11:813-820.
62. Ha S., Ou Y., Vlasak J., Li Y., Wang S., Vo K., Du Y., Mach A., Fang Y., Zhang N. Isolation and characterization of IgG1 with asymmetrical Fc glycosylation. Glycobiology 2011, 21:1087-1096.
63. Hart G.W., Copeland R.J. Glycomics hits the big time. Cell 2010, 143:672-676.
64. Hebert D.N., Garman S.C., Molinari M. The glycan code of the endoplasmic reticulum: asparagine-linked carbohydrates as protein maturation and quality-control tags. Trends Cell Biol. 2005, 15:364-370.
65. Herscovics A. Structure and function of Class I alpha 1,2-mannosidases involved in glycoprotein synthesis and endoplasmic reticulum quality control. Biochimie 2001, 83:757-762.
66. Hitsumoto Y., Thompson S.J., Zhang Y.W., Rook G.A., Elson C.J. Relationship between interleukin 6, agalactosyl IgG and pristane-induced arthritis. Autoimmunity 1992, 11:247-254.
67. Holland M., Takada K., Okumoto T., Takahashi N., Kato K., Adu D., Ben Smith A., Harper L., Savage C.O., Jefferis R. Hypogalactosylation of serum IgG in patients with ANCA-associated systemic vasculitis. Clin. Exp. Immunol. 2002, 129:183-190.
68. Holland M., Yagi H., Takahashi N., Kato K., Savage C.O., Goodall D.M., Jefferis R. Differential glycosylation of polyclonal IgG, IgG-Fc and IgG-Fab isolated from the sera of patients with ANCA-associated systemic vasculitis. Biochim. Biophys. Acta 2006, 1760:669-677.
69. Hummasti S., Hotamisligil G.S. Endoplasmic reticulum stress and inflammation in obesity and diabetes. Circ. Res. 2010, 107:579-591.
70. Ihara Y., Nishikawa A., Tohma T., Soejima H., Niikawa N., Taniguchi N. cDNA cloning, expression, and chromosomal localization of human N-acetylglucosaminyltransferase III (GnT-III). J. Biochem. (Tokyo) 1993, 113:692-698.
71. Iida S., Kuni-Kamochi R., Mori K., Misaka H., Inoue M., Okazaki A., Shitara K., Satoh M. Two mechanisms of the enhanced antibody-dependent cellular cytotoxicity (ADCC) efficacy of non-fucosylated therapeutic antibodies in human blood. BMC Cancer 2009, 9:58.
72. Iida S., Misaka H., Inoue M., Shibata M., Nakano R., Yamane-Ohnuki N., Wakitani M., Yano K., Shitara K., Satoh M. Nonfucosylated therapeutic IgG1 antibody can evade the inhibitory effect of serum immunoglobulin G on antibody-dependent cellular cytotoxicity through its high binding to FcγRIIIa. Clin. Cancer Res. 2006, 12:2879-2887.
73. Imafuku Y., Yoshida H., Yamada Y. Reactivity of agalactosyl IgG with rheumatoid factor. Clin. Chim. Acta 2003, 334:217-223.
74. Isenberg D. Abnormalities in the glycosylation of IgG and its clinical utility. Adv. Exp. Med. Biol. 1995, 376:179-183.
75. Jeddi P., Keusch J., Lydyard P.M., Bodman-Smith K.B., Chesnutt M.S., Wofsy D., Hirota H., Taga T., Delves P.J. The effect on immunoglobulin glycosylation of altering in vivo production of immunoglobulin G. Immunology 1999, 98:475-480.
76. Jeddi P.A., Bodman-Smith K.B., Lund T., Lydyard P.M., Mengle-Gaw L., Isenberg D.A., Youinou P., Delves P.J. Agalactosyl IgG and β-1,4-galactosyltransferase gene expression in rheumatoid arthritis patients and in the arthritis-prone MRL lpr/lpr mouse. Immunology 1996, 87:654-659.
77. Jeddi P.A., Lund T., Bodman K.B., Sumar N., Lydyard P.M., Pouncey L., Heath L.S., Kidd V.J., Delves P.J. Reduced galactosyltransferase mRNA levels are associated with the agalactosyl IgG found in arthritis-prone MRL-lpr/lpr strain mice. Immunology 1994, 83:484-488.
78. Jefferis R., Lund J., Mizutani H., Nakagawa H., Kawazoe Y., Arata Y., Takahashi N. A comparative study of the N-linked oligosaccharide structures of human IgG subclass proteins. Biochem. J. 1990, 268:529-537.
79. Kaneko Y., Nimmerjahn F., Ravetch J.V. Anti-inflammatory activity of immunoglobulin G resulting from Fc sialylation. Science 2006, 313:670-673.
80. Kanoh Y., Mashiko T., Danbara M., Takayama Y., Ohtani S., Egawa S., Baba S., Akahoshi T. Changes in serum IgG oligosaccharide chains with prostate cancer progression. Anticancer Res. 2004, 24:3135-3139.
81. Kanoh Y., Mashiko T., Danbara M., Takayama Y., Ohtani S., Imasaki T., Abe T., Akahoshi T. Analysis of the oligosaccharide chain of human serum immunoglobulin G in patients with localized or metastatic cancer. Oncology 2004, 66:365-370.
82. Kanoh Y., Ohara T., Mashiko T., Abe T., Masuda N., Akahoshi T. Relationship between N-linked oligosaccharide chains of human serum immunoglobulin G and serum tumor markers with non-small cell lung cancer progression. Anticancer Res. 2006, 26:4293-4297.
83. Kanoh Y., Ohara T., Tadano T., Kanoh M., Akahoshi T. Changes to N-linked oligosaccharide chains of human serum immunoglobulin G and matrix metalloproteinase-2 with cancer progression. Anticancer Res. 2008, 28:715-720.
84. Keusch J., Lydyard P.M., Berger E.G., Delves P.J. B lymphocyte galactosyltransferase protein levels in normal individuals and in patients with rheumatoid arthritis. Glycoconj. J. 1998, 15:1093-1097.
85. Keusch J., Lydyard P.M., Delves P.J. The effect on IgG glycosylation of altering β1,4-galactosyltransferase-1 activity in B cells. Glycobiology 1998, 8:1215-1220.
86. Kibe T., Fujimoto S., Ishida C., Togari H., Wada Y., Okada S., Nakagawa H., Tsukamoto Y., Takahashi N. Glycosylation and placental transport of Immunoglobulin G. J. Clin. Biochem. Nutr. 1996, 21:57-63.
87. Kido M., Asano M., Iwakura Y., Ichinose M., Miki K., Furukawa K. Normal levels of serum glycoproteins maintained in β-1,4-galactosyltransferase I-knockout mice. FEBS Lett. 1999, 464:75-79.
88. Kiss J.Z., Rougon G. Cell biology of polysialic acid. Curr. Opin. Neurobiol. 1997, 7:640-646.
89. Kjeldsen-Kragh J., Sumar N., Bodman-Smith K., Brostoff J. Changes in glycosylation of IgG during fasting in patients with rheumatoid arthritis. Br. J. Rheumatol. 1996, 35:117-119.
90. Knezevic A., Gornik O., Polasek O., Pucic M., Redzic I., Novokmet M., Rudd P.M., Wright A.F., Campbell H., Rudan I., Lauc G. Effects of aging, body mass index, plasma lipid profiles, and smoking on human plasma N-glycans. Glycobiology 2010, 20:959-969.
91. Knezevic A., Polasek O., Gornik O., Rudan I., Campbell H., Hayward C., Wright A., Kolcic I., O'Donoghue N., Bones J., Rudd P.M., Lauc G. Variability, heritability and environmental determinants of human plasma N-glycome. J. Proteome Res. 2009, 8:694-701.
92. Kobata A. Glycobiology in the field of aging research-introduction to glycogerontology. Biochimie 2003, 85:13-24.
93. Kono H., Rock K.L. How dying cells alert the immune system to danger. Nat. Rev. Immunol. 2008, 8:279-289.
94. Kornfeld R., Kornfeld S. Assembly of asparagine-linked oligosaccharides. Annu. Rev. Biochem. 1985, 54:631-664.
95. Kotani N., Asano M., Iwakura Y., Takasaki S. Knockout of mouse β1,4-galactosyltransferase-1 gene results in a dramatic shift of outer chain moieties of N-glycans from type 2 to type 1 chains in hepatic membrane and plasma glycoproteins. Biochem. J. 2001, 357:827-834.
96. Krapp S., Mimura Y., Jefferis R., Huber R., Sondermann P. Structural analysis of human IgG-Fc glycoforms reveals a correlation between glycosylation and structural integrity. J. Mol. Biol. 2003, 325:979-989.
97. Kumpel B.M., Wang Y., Griffiths H.L., Hadley A.G., Rook G.A. The biological activity of human monoclonal IgG anti-D is reduced by β-galactosidase treatment. Hum. Antibodies Hybridomas 1995, 6:82-88.
98. Kuroda Y., Nakata M., Hirose S., Shirai T., Iwamoto M., Izui S., Kojima N., Mizuochi T. Abnormal IgG galactosylation in MRL-lpr/lpr mice: pathogenic role in the development of arthritis. Pathol. Int. 2001, 51:909-915.
99. Kuroda Y., Nakata M., Nose M., Kojima N., Mizuochi T. Abnormal IgG galactosylation and arthritis in MRL-Fas(lpr) or MRL-FasL(gld) mice are under the control of the MRL genetic background. FEBS Lett. 2001, 507:210-214.
100. Laroy W., Contreras R., Callewaert N. Glycome mapping on DNA sequencing equipment. Nat. Protoc. 2006, 1:397-405.
101. Lastra G.C., Thompson S.J., Lemonidis A.S., Elson C.J. Changes in the galactose content of IgG during humoral immune responses. Autoimmunity 1998, 28:25-30.
102. Lau K.S., Partridge E.A., Grigorian A., Silvescu C.I., Reinhold V.N., Demetriou M., Dennis J.W. Complex N-glycan number and degree of branching cooperate to regulate cell proliferation and differentiation. Cell 2007, 129:123-134.
103. Lauc G., Essafi A., Huffman J.E., Hayward C., Knezevic A., Kattla J.J., Polasek O., Gornik O., Vitart V., Abrahams J.L., Pucic M., Novokmet M., Redzic I., Campbell S., Wild S.H., Borovecki F., Wang W., Kolcic I., Zgaga L., Gyllensten U., Wilson J.F., Wright A.F., Hastie N.D., Campbell H., Rudd P.M., Rudan I. Genomics meets glycomics-the first GWAS study of human N-glycome identifies HNF1α as a master regulator of plasma protein fucosylation. PLoS Genet. 2010, 6:e1001256.
104. Lauc G., Rudd P.M., Rudan I. Genome-wide association study identifies FUT8 and ESR2 as co-regulators of a bi-antennary N-linked glycan A2 (GlcNAc2Man3GlcNAc2) in human plasma proteins. Nat. Precedings 2009, hdl:10101/npre.2009.2864.1, in press.
105. Leader K.A., Lastra G.C., Kirwan J.R., Elson C.J. Agalactosyl IgG in aggregates from the rheumatoid joint. Br. J. Rheumatol. 1996, 35:335-341.
106. Lee M., Lee H.J., Bae S., Lee Y.S. Protein sialylation by sialyltransferase involves radiation resistance. Mol. Cancer Res. 2008, 6:1316-1325.
107. Leirisalo-Repo M., Hernandez-Munoz H.E., Rook G.A. Agalactosyl IgG is elevated in patients with active spondyloarthropathy. Rheumatol. Int. 1999, 18:171-176.
108. Liu Y.L., Lu W.C., Brummel T.J., Yuh C.H., Lin P.T., Kao T.Y., Li F.Y., Liao P.C., Benzer S., Wang H.D. Reduced expression of α-1,2-mannosidase I extends lifespan in Drosophila melanogaster and Caenorhabditis elegans. Aging Cell 2009, 8:370-379.
109. Maeno N., Takei S., Fujikawa S., Yamada Y., Imanaka H., Hokonohara M., Kawano Y., Oda H. Antiagalactosyl IgG antibodies in juvenile idiopathic arthritis, juvenile onset Sjogren's syndrome, and healthy children. J. Rheumatol. 2004, 31:1211-1217.
110. Malhotra R., Wormald M.R., Rudd P.M., Fischer P.B., Dwek R.A., Sim R.B. Glycosylation changes of IgG associated with rheumatoid arthritis can activate complement via the mannose-binding protein. Nat. Med. 1995, 1:237-243.
111. Marcos N.T., Magalhaes A., Ferreira B., Oliveira M.J., Carvalho A.S., Mendes N., Gilmartin T., Head S.R., Figueiredo C., David L., Santos-Silva F., Reis C.A. Helicobacter pylori induces β3GnT5 in human gastric cell lines, modulating expression of the SabA ligand sialyl-Lewis x. J. Clin. Invest. 2008, 118:2325-2336.
112. Martin K., Talukder R., Hay F.C., Axford J.S. Characterization of changes in IgG associated oligosaccharide profiles in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis using fluorophore linked carbohydrate electrophoresis. J. Rheumatol. 2001, 28:1531-1536.
113. Matsumoto A., Shikata K., Takeuchi F., Kojima N., Mizuochi T. Autoantibody activity of IgG rheumatoid factor increases with decreasing levels of galactosylation and sialylation. J. Biochem. (Tokyo) 2000, 128:621-628.
114. Mattu T.S., Pleass R.J., Willis A.C., Kilian M., Wormald M.R., Lellouch A.C., Rudd P.M., Woof J.M., Dwek R.A. The glycosylation and structure of human serum IgA1, Fab, and Fc regions and the role of N-glycosylation on Fc alpha receptor interactions. J. Biol. Chem. 1998, 273:2260-2272.
115. Mehta A.S., Long R.E., Comunale M.A., Wang M., Rodemich L., Krakover J., Philip R., Marrero J.A., Dwek R.A., Block T.M. Increased levels of galactose-deficient anti-Gal immunoglobulin G in the sera of hepatitis C virus-infected individuals with fibrosis and cirrhosis. J. Virol. 2008, 82:1259-1270.
116. Mimura Y., Ashton P.R., Takahashi N., Harvey D.J., Jefferis R. Contrasting glycosylation profiles between Fab and Fc of a human IgG protein studied by electrospray ionization mass spectrometry. J. Immunol. Methods 2007, 326:116-126.
117. Mimura Y., Ihn H., Jinnin M., Asano Y., Yamane K., Tamaki K. Rheumatoid factor isotypes in localized scleroderma. Clin. Exp. Dermatol. 2005, 30:405-408.
118. Mimura Y., Ihn H., Jinnin M., Asano Y., Yamane K., Yazawa N., Tamaki K. Rheumatoid factor isotypes and anti-agalactosyl IgG antibodies in systemic sclerosis. Br. J. Dermatol. 2004, 151:803-808.
119. Mimura Y., Ihn H., Jinnin M., Asano Y., Yamane K., Yazawa N., Tamaki K. Serum levels of anti-agalactosyl IgG antibodies in mixed connective tissue disease. Br. J. Dermatol. 2005, 152:806-807.
120. Molinari M. N-glycan structure dictates extension of protein folding or onset of disposal. Nat. Chem. Biol. 2007, 3:313-320.
121. Nakagawa H., Hato M., Takegawa Y., Deguchi K., Ito H., Takahata M., Iwasaki N., Minami A., Nishimura S. Detection of altered N-glycan profiles in whole serum from rheumatoid arthritis patients. J. Chromatogr. B: Anal. Technol. Biomed. Life Sci. 2007, 853:133-137.
122. Nakajima S., Iijima H., Shinzaki S., Egawa S., Inoue T., Mukai A., Hayashi Y., Kondo J., Akasaka T., Nishida T., Kanto T., Morii E., Mizushima T., Miyoshi E., Tsujii M., Hayashi N. Functional analysis of agalactosyl IgG in inflammatory bowel disease patients. Inflamm. Bowel Dis. 2011, 17:927-936.
123. Nakao H., Nishikawa A., Nishiura T., Kanayama Y., Tarui S., Taniguchi N. Hypogalactosylation of immunoglobulin G sugar chains and elevated serum interleukin 6 in Castleman's disease. Clin. Chim. Acta 1991, 197:221-228.
124. Narasimhan S. Control of glycoprotein synthesis. UDP-GlcNAc:glycopeptide β4-N-acetylglucosaminyltransferase III, an enzyme in hen oviduct which adds GlcNAc in β1-4 linkage to the β-linked mannose of the trimannosyl core of N-glycosyl oligosaccharides. J. Biol. Chem. 1982, 257:10235-10242.
125. Nimmerjahn F., Anthony R.M., Ravetch J.V. Agalactosylated IgG antibodies depend on cellular Fc receptors for in vivo activity. Proc. Natl. Acad. Sci. U.S.A. 2007, 104:8433-8437.
126. Nimmerjahn F., Ravetch J.V. Fcγ receptors: old friends and new family members. Immunity 2006, 24:19-28.
127. Nimmerjahn F., Ravetch J.V. The antiinflammatory activity of IgG: the intravenous IgG paradox. J. Exp. Med. 2007, 204:11-15.
128. Nimmerjahn F., Ravetch J.V. Anti-inflammatory actions of intravenous immunoglobulin. Annu. Rev. Immunol. 2008, 26:513-533.
129. Nimmerjahn F., Ravetch J.V. Fcγ receptors as regulators of immune responses. Nat. Rev. Immunol. 2008, 8:34-47.
130. Nishijima C., Sato S., Takehara K. Anti-agalactosyl IgG antibodies in sera from patients with systemic sclerosis. J. Rheumatol. 2001, 28:1847-1851.
131. Niwa R., Natsume A., Uehara A., Wakitani M., Iida S., Uchida K., Satoh M., Shitara K. IgG subclass-independent improvement of antibody-dependent cellular cytotoxicity by fucose removal from Asn297-linked oligosaccharides. J. Immunol. Methods 2005, 306:151-160.
132. Ohtsubo K., Marth J.D. Glycosylation in cellular mechanisms of health and disease. Cell 2006, 126:855-867.
133. Ohyama C., Kanto S., Kato K., Nakano O., Arai Y., Kato T., Chen S., Fukuda M.N., Fukuda M. Natural killer cells attack tumor cells expressing high levels of sialyl Lewis x oligosaccharides. Proc. Natl. Acad. Sci. U.S.A. 2002, 99:13789-13794.
134. Omtvedt L.A., Royle L., Husby G., Sletten K., Radcliffe C.M., Harvey D.J., Dwek R.A., Rudd P.M. Glycan analysis of monoclonal antibodies secreted in deposition disorders indicates that subsets of plasma cells differentially process IgG glycans. Arthritis Rheum. 2006, 54:3433-3440.
135. Pang P.C., Chiu P.C., Lee C.L., Chang L.Y., Panico M., Morris H.R., Haslam S.M., Khoo K.H., Clark G.F., Yeung W.S., Dell A. Human sperm binding is mediated by the sialyl-Lewis x oligosaccharide on the zona pellucida. Science 2011, 333:1761-1764.
136. Parekh R., Isenberg D., Rook G., Roitt I., Dwek R., Rademacher T. A comparative analysis of disease-associated changes in the galactosylation of serum IgG. J. Autoimmun. 1989, 2:101-114.
137. Parekh R., Roitt I., Isenberg D., Dwek R., Rademacher T. Age-related galactosylation of the N-linked oligosaccharides of human serum IgG. J. Exp. Med. 1988, 167:1731-1736.
138. Parekh R.B., Dwek R.A., Rademacher T.W. Rheumatoid arthritis as a glycosylation disorder. Br. J. Rheumatol. 1988, 27(Suppl 2):162-169.
139. Parekh R.B., Dwek R.A., Sutton B.J., Fernandes D.L., Leung A., Stanworth D., Rademacher T.W., Mizuochi T., Taniguchi T., Matsuta K., Takeuki F., Nagano Y., Miyamoto T., Kobata A. Association of rheumatoid arthritis and primary osteoarthritis with changes in the glycosylation pattern of total serum IgG. Nature 1985, 316:452-457.
140. Parekh R.B., Roitt I.M., Isenberg D.A., Dwek R.A., Ansell B.M., Rademacher T.W. Galactosylation of IgG associated oligosaccharides: reduction in patients with adult and juvenile onset rheumatoid arthritis and relation to disease activity. Lancet 1988, 1:966-969.
141. Pasek M., Duk M., Podbielska M., Sokolik R., Szechinski J., Lisowska E., Krotkiewski H. Galactosylation of IgG from rheumatoid arthritis (RA) patients-changes during therapy. Glycoconj. J. 2006, 23:463-471.
142. Peipp M., Lammerts van Bueren J.J., Schneider-Merck T., Bleeker W.W., Dechant M., Beyer T., Repp R., van Berkel P.H., Vink T., van de Winkel J.G., Parren P.W., Valerius T. Antibody fucosylation differentially impacts cytotoxicity mediated by NK and PMN effector cells. Blood 2008, 112:2390-2399.
143. Pekelharing J.M., Hepp E., Kamerling J.P., Gerwig G.J., Leijnse B. Alterations in carbohydrate composition of serum IgG from patients with rheumatoid arthritis and from pregnant women. Ann. Rheum. Dis. 1988, 47:91-95.
144. Perdivara I., Peddada S.D., Miller F.W., Tomer K.B., Deterding L.J. Mass spectrometric determination of IgG subclass-specific glycosylation profiles in siblings discordant for myositis syndromes. J. Proteome Res. 2011, 10:2969-2978.
145. x. Science 1990, 250:1130-1132.
146. Pierce A., Saldova R., Abd Hamid U.M., Abrahams J.L., McDermott E.W., Evoy D., Duffy M.J., Rudd P.M. Levels of specific glycans significantly distinguish lymph node-positive from lymph node-negative breast cancer patients. Glycobiology 2010, 20:1283-1288.
147. Pilkington C., Basaran M., Barlan I., Costello A.M., Rook G.A. Raised levels of agalactosyl IgG in childhood tuberculosis. Trans. R. Soc. Trop. Med. Hyg. 1996, 90:167-168.
148. Pilkington C., Lefvert A.K., Rook G.A. Neonatal myasthenia gravis and the role of agalactosyl IgG. Autoimmunity 1995, 21:131-135.
149. Pilkington C., Taylor P.V., Silverman E., Isenberg D.A., Costello A.M., Rook G.A. Agalactosyl IgG and materno-fetal transmission of autoimmune neonatal lupus. Rheumatol. Int. 1996, 16:89-94.
150. Pilkington C., Yeung E., Isenberg D., Lefvert A.K., Rook G.A. Agalactosyl IgG and antibody specificity in rheumatoid arthritis, tuberculosis, systemic lupus erythematosus and myasthenia gravis. Autoimmunity 1995, 22:107-111.
151. Pinho S.S., Seruca R., Gartner F., Yamaguchi Y., Gu J., Taniguchi N., Reis C.A. Modulation of E-cadherin function and dysfunction by N-glycosylation. Cell Mol. Life Sci. 2011, 68:1011-1020.
152. Pucic M., Knezevic A., Vidic J., Adamczyk B., Novokmet M., Polasek O., Gornik O., Supraha-Goreta S., Wormald M.R., Redzic I., Campbell H., Wright A., Hastie N.D., Wilson J.F., Rudan I., Wuhrer M., Rudd P.M., Josic D., Lauc G. High throughput isolation and glycosylation analysis of IgG-variability and heritability of the IgG glycome in three isolated human populations. Mol. Cell. Proteomics 2011, 10:M111.
153. Pucic M., Pinto S., Novokmet M., Knezevic A., Gornik O., Polasek O., Vlahovicek K., Wang W., Rudd P.M., Wright A.F., Campbell H., Rudan I., Lauc G. Common aberrations from the normal human plasma N-glycan profile. Glycobiology 2010, 20:970-975.
154. Rademacher T.W. Network theory of glycosylation-etiologic and pathogenic implications of changes in IgG glycoform levels in autoimmunity. Semin. Cell Biol. 1991, 2:327-337.
155. Rademacher T.W., Parekh R.B., Dwek R.A., Isenberg D., Rook G., Axford J.S., Roitt I. The role of IgG glycoforms in the pathogenesis of rheumatoid arthritis. Springer Semin. Immunopathol. 1988, 10:231-249.
156. Rademacher T.W., Williams P., Dwek R.A. Agalactosyl glycoforms of IgG autoantibodies are pathogenic. Proc. Natl. Acad. Sci. U.S.A. 1994, 91:6123-6127.
157. Raju T.S. Terminal sugars of Fc glycans influence antibody effector functions of IgGs. Curr. Opin. Immunol. 2008, 20:471-478.
158. Rook G., Thompson S., Buckley M., Elson C., Brealey R., Lambert C., White T., Rademacher T. The role of oil and agalactosyl IgG in the induction of arthritis in rodent models. Eur. J. Immunol. 1991, 21:1027-1032.
159. Rook G.A., Onyebujoh P., Wilkins E., Ly H.M., al Attiyah R., Bahr G., Corrah T., Hernandez H., Stanford J.L. A longitudinal study of per cent agalactosyl IgG in tuberculosis patients receiving chemotherapy, with or without immunotherapy. Immunology 1994, 81:149-154.
160. Rook G.A., Steele J., Brealey R., Whyte A., Isenberg D., Sumar N., Nelson J.L., Bodman K.B., Young A., Roitt I.M., Williams P., Scragg I.G., Edge C.I., Arkwright P.D., Ashford D., Wormald M.R., Rudd P.M., Redman C.W.G., Dwek R., Rademacher T. Changes in IgG glycoform levels are associated with remission of arthritis during pregnancy. J. Autoimmun. 1991, 4:779-794.
161. Royle L., Campbell M.P., Radcliffe C.M., White D.M., Harvey D.J., Abrahams J.L., Kim Y.G., Henry G.W., Shadick N.A., Weinblatt M.E., Lee D.M., Rudd P.M., Dwek R.A. HPLC-based analysis of serum N-glycans on a 96-well plate platform with dedicated database software. Anal. Biochem. 2008, 376:1-12.
162. Rudd P.M., Elliott T., Cresswell P., Wilson I.A., Dwek R.A. Glycosylation and the immune system. Science 2001, 291:2370-2376.
163. Ruhaak L.R., Hennig R., Huhn C., Borowiak M., Dolhain R.J., Deelder A.M., Rapp E., Wuhrer M. Optimized workflow for preparation of APTS-labeled N-glycans allowing high-throughput analysis of human plasma glycomes using 48-channel multiplexed CGE-LIF. J. Proteome Res. 2010, 9:6655-6664.
164. Ruhaak L.R., Huhn C., Waterreus W.J., de Boer A.R., Neususs C., Hokke C.H., Deelder A.M., Wuhrer M. Hydrophilic interaction chromatography-based high-throughput sample preparation method for N-glycan analysis from total human plasma glycoproteins. Anal. Chem. 2008, 80:6119-6126.
165. Ruhaak L.R., Uh H.W., Beekman M., Hokke C.H., Westendorp R.G., Houwing-Duistermaat J., Wuhrer M., Deelder A.M., Slagboom P.E. Plasma protein N-glycan profiles are associated with calendar age, familial longevity and health. J. Proteome Res. 2011, 10:1667-1674.
166. Ruhaak L.R., Uh H.W., Beekman M., Koeleman C.A., Hokke C.H., Westendorp R.G., Wuhrer M., Houwing-Duistermaat J.J., Slagboom P.E., Deelder A.M. Decreased levels of bisecting GlcNAc glycoforms of IgG are associated with human longevity. PLoS ONE 2010, 5:e12566.
167. Saldova R., Royle L., Radcliffe C.M., Abd Hamid U.M., Evans R., Arnold J.N., Banks R.E., Hutson R., Harvey D.J., Antrobus R., Petrescu S.M., Dwek R.A., Rudd P.M. Ovarian cancer is associated with changes in glycosylation in both acute-phase proteins and IgG. Glycobiology 2007, 17:1344-1356.
168. Sato Y., Kimura M., Endo T. Comparison of lectin-binding patterns between young adults and older rat glycoproteins in the brain. Glycoconj. J. 1998, 15:1133-1140.
169. Satoh M., Iida S., Shitara K. Non-fucosylated therapeutic antibodies as next-generation therapeutic antibodies. Expert Opin. Biol. Ther. 2006, 6:1161-1173.
170. Scallon B.J., Tam S.H., McCarthy S.G., Cai A.N., Raju T.S. Higher levels of sialylated Fc glycans in immunoglobulin G molecules can adversely impact functionality. Mol. Immunol. 2007, 44:1524-1534.
171. Scherer H.U., van der W.D., Ioan-Facsinay A., el Bannoudi H., Trouw L.A., Wang J., Haupl T., Burmester G.R., Deelder A.M., Huizinga T.W., Wuhrer M., Toes R.E. Glycan profiling of anti-citrullinated protein antibodies isolated from human serum and synovial fluid. Arthritis Rheum. 2010, 62:1620-1629.
172. Schumacher B., van d.P.I., Moorhouse M.J., Kosteas T., Robinson A.R., Suh Y., Breit T.M., van Steeg H., Niedernhofer L.J., van Ijcken W., Bartke A., Spindler S.R., Hoeijmakers J.H., van der Horst G.T., Garinis G.A. Delayed and accelerated aging share common longevity assurance mechanisms. PLoS Genet. 2008, 4:e1000161.
173. Selman M.H., Niks E.H., Titulaer M.J., Verschuuren J.J., Wuhrer M., Deelder A.M. IgG Fc N-glycosylation changes in Lambert-Eaton myasthenic syndrome and myasthenia gravis. J. Proteome Res. 2011, 10:143-152.
174. Shaikh F.M., Seales E.C., Clem W.C., Hennessy K.M., Zhuo Y., Bellis S.L. Tumor cell migration and invasion are regulated by expression of variant integrin glycoforms. Exp. Cell Res. 2008, 314:2941-2950.
175. Shibata-Koyama M., Iida S., Misaka H., Mori K., Yano K., Shitara K., Satoh M. Nonfucosylated rituximab potentiates human neutrophil phagocytosis through its high binding for FcγRIIIb and MHC class II expression on the phagocytotic neutrophils. Exp. Hematol. 2009, 37:309-321.
176. Shibuya N., Goldstein I.J., Broekaert W.F., Nsimba-Lubaki M., Peeters B., Peumans W.J. The elderberry (Sambucus nigra L.) bark lectin recognizes the Neu5Ac(α 2-6)Gal/GalNAc sequence. J. Biol. Chem. 1987, 262:1596-1601.
177. Shields R.L., Lai J., Keck R., O'Connell L.Y., Hong K., Meng Y.G., Weikert S.H., Presta L.G. Lack of fucose on human IgG1 N-linked oligosaccharide improves binding to human Fcγ RIII and antibody-dependent cellular toxicity. J. Biol. Chem. 2002, 277:26733-26740.
178. Shikata K., Yasuda T., Takeuchi F., Konishi T., Nakata M., Mizuochi T. Structural changes in the oligosaccharide moiety of human IgG with aging. Glycoconj. J. 1998, 15:683-689.
179. Shinkawa T., Nakamura K., Yamane N., Shoji-Hosaka E., Kanda Y., Sakurada M., Uchida K., Anazawa H., Satoh M., Yamasaki M., Hanai N., Shitara K. The absence of fucose but not the presence of galactose or bisecting N-acetylglucosamine of human IgG1 complex-type oligosaccharides shows the critical role of enhancing antibody-dependent cellular cytotoxicity. J. Biol. Chem. 2003, 278:3466-3473.
180. Shinzaki S., Iijima H., Nakagawa T., Egawa S., Nakajima S., Ishii S., Irie T., Kakiuchi Y., Nishida T., Yasumaru M., Kanto T., Tsujii M., Tsuji S., Mizushima T., Yoshihara H., Kondo A., Miyoshi E., Hayashi N. IgG oligosaccharide alterations are a novel diagnostic marker for disease activity and the clinical course of inflammatory bowel disease. Am. J. Gastroenterol. 2008, 103:1173-1181.
181. Soltys A.J., Hay F.C., Bond A., Axford J.S., Jones M.G., Randen I., Thompson K.M., Natvig J.B. The binding of synovial tissue-derived human monoclonal immunoglobulin M rheumatoid factor to immunoglobulin G preparations of differing galactose content. Scand. J. Immunol. 1994, 40:135-143.
182. Stanworth S.J., Donn R.P., Hassall A., Dawes P., Ollier W., Snowden N. Absence of an association between mannose-binding lectin polymorphism and rheumatoid arthritis. Br. J. Rheumatol. 1998, 37:186-188.
183. Sumar N., Isenberg D.A., Bodman K.B., Soltys A., Young A., Leak A.M., Round J., Hay F.C., Roitt I.M. Reduction in IgG galactose in juvenile and adult onset rheumatoid arthritis measured by a lectin binding method and its relation to rheumatoid factor. Ann. Rheum. Dis. 1991, 50:607-610.
184. Swindall A.F., Bellis S.L. Sialylation of the Fas death receptor by ST6Gal-I provides protection against Fas-mediated apoptosis in colon carcinoma cells. J. Biol. Chem. 2011, 286:22982-22990.
185. Tchkonia T., Morbeck D.E., Von Zglinicki T., Van Deursen J., Lustgarten J., Scrable H., Khosla S., Jensen M.D., Kirkland J.L. Fat tissue, aging, and cellular senescence. Aging Cell 2010, 9:667-684.
186. Tei K., Kawakami-Kimura N., Taguchi O., Kumamoto K., Higashiyama S., Taniguchi N., Toda K., Kawata R., Hisa Y., Kannagi R. Roles of cell adhesion molecules in tumor angiogenesis induced by cotransplantation of cancer and endothelial cells to nude rats. Cancer Res. 2002, 62:6289-6296.
187. Terai I., Kobayashi K., Vaerman J.P., Mafune N. Degalactosylated and/or denatured IgA, but not native IgA in any form, bind to mannose-binding lectin. J. Immunol. 2006, 177:1737-1745.
188. Thompson S.J., Hitsumoto Y., Zhang Y.W., Rook G.A., Elson C.J. Agalactosyl IgG in pristane-induced arthritis. Pregnancy affects the incidence and severity of arthritis and the glycosylation status of IgG. Clin. Exp. Immunol. 1992, 89:434-438.
189. Tomaiuolo R., Ruocco A., Salapete C., Carru C., Baggio G., Franceschi C., Zinellu A., Vaupel J., Bellia C., Lo S.B., Ciaccio M., Castaldo G., Deiana L. Activity of mannose-binding lectin (MBL) in centenarians. Aging Cell 2012, doi:10.1111/j.1474-9726.2012.00793.x, in press.
190. Troelsen L.N., Garred P., Madsen H.O., Jacobsen S. Genetically determined high serum levels of mannose-binding lectin and agalactosyl IgG are associated with ischemic heart disease in rheumatoid arthritis. Arthritis Rheum. 2007, 56:21-29.
191. Tsuchiya N., Endo T., Kochibe N., Ito K., Kobata A. Use of lectin for detection of agalactosyl IgG. Methods Mol. Med. 1998, 9:195-205.
192. Tsuchiya N., Endo T., Matsuta K., Yoshinoya S., Takeuchi F., Nagano Y., Shiota M., Furukawa K., Kochibe N., Ito K. Detection of glycosylation abnormality in rheumatoid IgG using N-acetylglucosamine-specific Psathyrella velutina lectin. J. Immunol. 1993, 151:1137-1146.
193. Umana P., Jean-Mairet J., Moudry R., Amstutz H., Bailey J.E. Engineered glycoforms of an antineuroblastoma IgG1 with optimized antibody-dependent cellular cytotoxic activity. Nat. Biotechnol. 1999, 17:176-180.
194. Van Beneden K., Coppieters K., Laroy W., De Keyser F., Hoffman I.E., Van den B.F., Vander C.B., Drennan M., Jacques P., Rottiers P., Verbruggen G., Contreras R., Callewaert N., Elewaut D. Reversible changes in serum immunoglobulin galactosylation during the immune response and treatment of inflammatory autoimmune arthritis. Ann. Rheum. Dis. 2009, 68:1360-1365.
195. van de Geijn F.E., Wuhrer M., Selman M.H., Willemsen S.P., de Man Y.A., Deelder A.M., Hazes J.M., Dolhain R.J. Immunoglobulin G galactosylation and sialylation are associated with pregnancy-induced improvement of rheumatoid arthritis and the postpartum flare: results from a large prospective cohort study. Arthritis Res. Ther. 2009, 11:R193.
196. Van Zeben D., Rook G.A., Hazes J.M., Zwinderman A.H., Zhang Y., Ghelani S., Rademacher T.W., Breedveld F.C. Early agalactosylation of IgG is associated with a more progressive disease course in patients with rheumatoid arthritis: results of a follow-up study. Br. J. Rheumatol. 1994, 33:36-43.
197. Vanhooren V., Desmyter L., Liu X.E., Cardelli M., Franceschi C., Federico A., Libert C., Laroy W., Dewaele S., Contreras R., Chen C. N-glycomic changes in serum proteins during human aging. Rejuvenation Res. 2007, 10:521-531.
198. Vanhooren V., Dewaele S., Kuro O., Taniguchi N., Dolle L., van Grunsven L.A., Makrantonaki E., Zouboulis C.C., Chen C.C., Libert C. Alteration in N-glycomics during mouse aging: a role for FUT8. Aging Cell 2011, 10:1056-1066.
199. Vanhooren V., Dewaele S., Libert C., Engelborghs S., De Deyn P.P., Toussaint O., Debacq-Chainiaux F., Poulain M., Glupczynski Y., Franceschi C., Jaspers K., van d.P., Hoeijmakers I., Chen J., Serum C.C. N-glycan profile shift during human ageing. Exp. Gerontol. 2010, 45:738-743.
200. Vanhooren V., Laroy W., Libert C., Chen C. N-Glycan profiling in the study of human aging. Biogerontology 2008, 9:351-356.
201. Vanhooren V., Liu X.E., Franceschi C., Gao C.F., Libert C., Contreras R., Chen C. N-glycan profiles as tools in diagnosis of hepatocellular carcinoma and prediction of healthy human ageing. Mech. Ageing Dev. 2009, 130:92-97.
202. Varki A. Biological roles of oligosaccharides: all of the theories are correct. Glycobiology 1993, 3:97-130.
203. Vescovini R., Biasini C., Fagnoni F.F., Telera A.R., Zanlari L., Pedrazzoni M., Bucci L., Monti D., Medici M.C., Chezzi C., Franceschi C., Sansoni P. Massive load of functional effector CD4+ and CD8+ T cells against cytomegalovirus in very old subjects. J. Immunol. 2007, 179:4283-4291.
204. Wang J., Balog C.I., Stavenhagen K., Koeleman C.A., Scherer H.U., Selman M.H., Deelder A.M., Huizinga T.W., Toes R.E., Wuhrer M. Fc-glycosylation of IgG1 is modulated by B-cell stimuli. Mol. Cell. Proteomics 2011, 10:M110.
205. Weindruch R., Naylor P.H., Goldstein A.L., Walford R.L. Influences of aging and dietary restriction on serum thymosin α 1 levels in mice. J. Gerontol. 1988, 43:B40-B42.
206. Williams P.J., Arkwright P.D., Rudd P., Scragg I.G., Edge C.J., Wormald M.R., Rademacher T.W. Short communication: selective placental transport of maternal IgG to the fetus. Placenta 1995, 16:749-756.
207. Wong S.Y., Manger I.D., Guile G.R., Rademacher T.W., Dwek R.A. Analysis of carbohydrate-protein interactions with synthetic N-linked neoglycoconjugate probes. Biochem. J. 1993, 296(Pt 3):817-825.
208. Wormald M.R., Rudd P.M., Harvey D.J., Chang S.C., Scragg I.G., Dwek R.A. Variations in oligosaccharide-protein interactions in immunoglobulin G determine the site-specific glycosylation profiles and modulate the dynamic motion of the Fc oligosaccharides. Biochemistry 1997, 36:1370-1380.
209. Wuhrer M., de Boer A.R., Deelder A.M. Structural glycomics using hydrophilic interaction chromatography (HILIC) with mass spectrometry. Mass Spectrom. Rev. 2009, 28:192-206.
210. Yabe R., Tateno H., Hirabayashi J. Frontal affinity chromatography analysis of constructs of DC-SIGN, DC-SIGNR and LSECtin extend evidence for affinity to agalactosylated N-glycans. FEBS J. 2010, 277:4010-4026.
211. Yagev H., Frenkel A., Cohen I.R., Friedman A. Adjuvant arthritis is associated with changes in the glycosylation of serum IgG1 and IgG2b. Clin. Exp. Immunol. 1993, 94:452-458.
212. Yamada E., Tsukamoto Y., Sasaki R., Yagyu K., Takahashi N. Structural changes of immunoglobulin G oligosaccharides with age in healthy human serum. Glycoconj. J. 1997, 14:401-405.
213. Yamada S., Suzuki Y., Suzuki T., Le M.Q., Nidom C.A., Sakai-Tagawa Y., Muramoto Y., Ito M., Kiso M., Horimoto T., Shinya K., Sawada T., Kiso M., Usui T., Murata T., Lin Y., Hay A., Haire L.F., Stevens D.J., Russell R.J., Gamblin S.J., Skehel J.J., Kawaoka Y. Haemagglutinin mutations responsible for the binding of H5N1 influenza A viruses to human-type receptors. Nature 2006, 444:378-382.
214. Yamaguchi Y., Nishimura M., Nagano M., Yagi H., Sasakawa H., Uchida K., Shitara K., Kato K. Glycoform-dependent conformational alteration of the Fc region of human immunoglobulin G1 as revealed by NMR spectroscopy. Biochim. Biophys. Acta 2006, 1760:693-700.
215. Yanagidani S., Uozumi N., Ihara Y., Miyoshi E., Yamaguchi N., Taniguchi N. Purification and cDNA cloning of GDP-L-Fuc:N-acetyl-β-d-glucosaminide:α1-6 fucosyltransferase (α1-6 FucT) from human gastric cancer MKN45 cells. J. Biochem. (Tokyo) 1997, 121:626-632.
216. Youings A., Chang S.C., Dwek R.A., Scragg I.G. Site-specific glycosylation of human immunoglobulin G is altered in four rheumatoid arthritis patients. Biochem. J. 1996, 314(Pt 2):621-630.
217. Young A., Sumar N., Bodman K., Goyal S., Sinclair H., Roitt I., Isenberg D. Agalactosyl IgG: an aid to differential diagnosis in early synovitis. Arthritis Rheum. 1991, 34:1425-1429.
218. Zhu M., Lovell K.L., Patterson J.S., Saunders T.L., Hughes E.D., Friderici K.H. Beta-mannosidosis mice: a model for the human lysosomal storage disease. Hum. Mol. Genet. 2006, 15:493-500.
219. Zou S., Meadows S., Sharp L., Jan L.Y., Jan Y.N. Genome-wide study of aging and oxidative stress response in Drosophila melanogaster. Proc. Natl. Acad. Sci. U.S.A. 2000, 97:13726-13731.